Oxford Nanopore wins over Amgen
Privately owned Oxford Nanopore Technologies Ltd announced Amgen’s equity investment of £50m (€57m). Oxford Nanopore’s sequencing technology uses...
EC advisors call for update of GM legislation
The seven advisiors of the EU Commission (SAM) call on the European Commission (EC) to revise the existing GMO directive 2001/18/EC because the...
Cellestia Biotech AG attracts Series A financing
The company, which is in Phase I testing of CB-103 in 25 patients with advanced blood cancers and solid tumours, said it will use the proceeds to...
Sugar replacement slows cancer growth
Feeding mannose either alone or alongside chemotherapy through a feeding tube three times a week and continuously via their drinking water was...
MEPs back €120bn budget for Horizon Europe
While the EU will miss its target to raise total public and private R&D spending in the EU to 3% of GDP by 2020 - in 2017 the EU average was...
New target for lung fibrosis discovered
Seeking for the reason why myofibroblasts, which normally secrete collagen in response to inflammatory signals to repair tissue injury in the lungs,...
Argenx antibody kills AML
Overall, 11 of 12 patients with acute myeloid leukemia (AML) enrolled within a Phase I dose finding study, responded to...